by The Mount Sinai Hospital Credit: CC0 Public Domain Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of the bladder have been identified and validated by researchers at Mount Sinai. In a study published in Clinical Cancer Research, the team uncovered gene signatures representing adaptive immunity and pro-tumorigenic inflammation that were responsible for sensitivity or...
January 16, 2021 by Study FindsSHARES32 BETHESDA, Md. — Aspirin is commonly linked to better heart health, especially when a patient is having a heart attack. Now, one study finds that taking a few tablets each week may also be the key to surviving certain cancers. Researchers with the National Cancer Institute say taking aspirin at least three...
by Markus Berninger, Max Planck Society The human immune system can recognize and eliminate not only germs but also cancer cells. This is why treatments with weakened germs can help the immune system in its fight against cancer. Researchers at the Max Planck Institute for Infection Biology in Berlin have genetically modified the tuberculosis vaccine...
By Rich Haridy A compelling new study from the World Health Organization’s International Agency for Research on Cancer (IARC) is suggesting a simple biomarker in urine may be an effective predictive test for bladder cancer, signaling the disease’s presence up to 10 years before clinical signs appear. Bladder cancer is a challenging type of cancer...
UNIVERSITY OF EAST ANGLIA A simple urine test under development for prostate cancer detection can now use urine samples collected at home – according to new research from University of East Anglia and the Norfolk and Norwich University Hospital. Scientists pioneered the test which diagnoses aggressive prostate cancer and predicts whether patients will require treatment...
By Michael Irving If movies have taught us anything, it’s that sometimes to fight one villain, you have to team up with another. Medical science occasionally follows the same logic and in the latest example, researchers have turned to anthrax as an unlikely ally in the fight against bladder cancer, with promising results in animal...
by Curtin University New Curtin University-led research has discovered that using drugs to target a pathway in the body that causes cancerous cells to spread aggressively may help to reduce the severity of bladder cancer. The research, published in Nature Communications, aimed to understand the function of two naturally occurring proteins called hepatocyte growth factor...
By Ana Sandoiu Fact checked by Isabel Godfrey New research presents a complex electronic device as a possible new, efficient, simple, and cost-effective way of detecting bladder cancer in its early stages and monitoring people living with bladder cancer. The American Cancer Society (ACS) estimate that bladder cancer will affect 80,470 people in the United States this year. About 17,670 deaths are...
by Medical College of Georgia at Augusta University Two new urine tests appear to accurately detect bladder cancer, determine its severity and detect its recurrence, investigators report. The tests look at activity and levels of V1, a gene variant upregulated in bladder cancer that dissolves natural sugars in the mucosal lining of the fist-sized bladder, making it more vulnerable to cancer. Investigators...
Philadelphia, PA, February 12, 2019 – Label-free digital pathology using infrared (IR) imaging with subsequent proteomic analysis for bladder cancer (BC) has revealed the first protein biomarker (AHNAK2) for BC. AHNAK2 differentiates between chronic cystitis (inflammation of the bladder) and a non-muscle invasive-type BC (carcinoma in situ) which is challenging to diagnose. A report in...
